The current pandemic SARS Cov 2 is shining a light on vaccine development. Since December 2019, the novel coronavirus is known amongst scientists. The virus is highly contagious. As a first measure, many governments all over the world have ordered a complete lockdown of the countries.
Some politicians make reverting life back to normal dependent on the existence of medication and/or vaccine. How long does it take to develop a vaccine against this novel coronavirus?
In this episode, the vaccine development expert Ericht Tauber, CEO, and founder of Themis Bioscience, explains what it takes to develop a novel vaccine and also gives an outlook on the timeline.
It was a huge pleasure to be accompanied by Elisabeth Pfneisl, Addendum.org, during the recording of this interview.
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Elisabeth Pfneisl (https://www.linkedin.com/in/elisabeth-pfneisl-81095163/)
Erich Tauber (https://www.linkedin.com/in/erich-tauber-0ba8a111/)
Companies:
Addendum.org (https://www.addendum.org/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Themis BioScience (https://themisbio.com/)
Do you enjoy the podcast?
Become a member of the LSG2G Network and join the recording. You will get an individual "member only" invitation and will have a chance to talk with the speakers directly in the Q&A. The questions will be featured in the podcast.
Do you like this idea? Join today: https://www.lifescienceget2gether.com/registration-membersclub/
Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)
The current pandemic SARS Cov 2 is shining a light on vaccine development. Since December 2019, the novel coronavirus is known amongst scientists. The virus is highly contagious. As a first measure, many governments all over the world have ordered a complete lockdown of the countries.
Some politicians make reverting life back to normal dependent on the existence of medication and/or vaccine. How long does it take to develop a vaccine against this novel coronavirus?
In this episode, the vaccine development expert Ericht Tauber, CEO, and founder of Themis Bioscience, explains what it takes to develop a novel vaccine and also gives an outlook on the timeline.
It was a huge pleasure to be accompanied by Elisabeth Pfneisl, Addendum.org, during the recording of this interview.
Speaker:
Christian Soschner (https://www.linkedin.com/in/christiansoschner/)
Elisabeth Pfneisl (https://www.linkedin.com/in/elisabeth-pfneisl-81095163/)
Erich Tauber (https://www.linkedin.com/in/erich-tauber-0ba8a111/)
Companies:
Addendum.org (https://www.addendum.org/)
CS Life Science Invest (https://www.cslifescienceinvest.com/)
Themis BioScience (https://themisbio.com/)
Do you enjoy the podcast?
Become a member of the LSG2G Network and join the recording. You will get an individual "member only" invitation and will have a chance to talk with the speakers directly in the Q&A. The questions will be featured in the podcast.
Do you like this idea? Join today: https://www.lifescienceget2gether.com/registration-membersclub/
Support the show (https://www.lifescienceget2gether.com/registration-membersclub/)